AKT1 and ovarian cancer: Mutations in this pathway are frequently associated with aberrant cell signaling and have been implicated in tumor growth and survival, suggesting that OVAR79 may serve as a useful model for studying PI3K/AKT pathway dysregulation in ovarian cancer [23,24].